Indigenous American Ancestry May Be Associated with Aggressive Breast Cancer Subtype
A new study finds that Latina women with a higher proportion of Indigenous American ancestry may be at increased...
A new study finds that Latina women with a higher proportion of Indigenous American ancestry may be at increased...
Immunotherapy may make surgery an option for patients who would be considered ineligible under traditional rules.ย Surgery is usually...
Researchers are seeking to understand why some patients do not respond to immunotherapeutics and to identify ways to ensure...
The use of lymphocytes to attack tumors may be less effective if given after other treatments, study published in...
In an early-phase trial, investigators study whether combining immunotherapies expands “tumor-specific immune activation.” A small phase Ib study of...
The FDA has approved an alternative dosing schedule for the immune checkpoint inhibitor pembrolizumab. On April 28, 2020, the...
An investigational immunotherapeutic was safe, tolerable, and showed some activity against melanoma in a phase I clinical trial The...
A recent study reports that how pediatricians talk to parents can affect whether or not they chose to have...
Study reports that alcohol, particularly white wine, consumption may be associated with higher risk for melanoma. A new study...
Despite progress, the Florida study found that the breast cancer death rate for Black women remained higher than for...
A new study involving normal-weight postmenopausal women found that poor metabolic health was associated with an increased risk for...
Sociodemographic factors may play a role in receiving immunotherapy PHILADELPHIA โ Data derived from a large real-world database showed...
Five new members elected to the Board of Directors PHILADELPHIA โ The members of the American Association for Cancer...
PHILADELPHIA โ The American Association for Cancer Research (AACR) will present the 2024 AACR Distinguished Public Service Award for...
PHILADELPHIA โ The American Association for Cancer Research (AACR) today announced its newly elected class of Fellows of the...
PHILADELPHIA โ Today, the American Association for Cancer Research (AACR) released the 14th edition of its annual Cancer Progress...
Awardees to be recognized at the AACR Annual Meeting 2024 in San Diego PHILADELPHIA โ The American Association for...
Mutations were detected via circulating tumor DNA before disease progression in patients treated with an aromatase inhibitor/palbociclib for hormone...
PHILADELPHIA โ The American Association for Cancer Research (AACR) today announced its newest class of grant recipients. Since 1993, the AACR...
Five new members elected to the Board of Directors PHILADELPHIA โ The members of the American Association for Cancer...
SAN DIEGO โ A video designed to educate Black men about prostate cancer resulted in 97% of surveyed participants...
Patricia M. LoRusso, DO, PhD (hc), FAACR, begins term as AACR President SAN DIEGO โ The members of the...
Report features latest statistics and nine compelling patient stories PHILADELPHIA โ The American Association for Cancer Research (AACR) today...
Clinical benefit was independent of patientsโ tumor mutational burden ORLANDO, Fla. โ mRNA-4157/V940, a personalized mRNA-based cancer vaccine,...
SAN ANTONIO โ In patients with hormone receptor (HR)-positive, HER2-negative tumors resistant to aromatase inhibitors, addition of the investigational...
PHILADELPHIA โ The American Association for Cancer Research (AACR) will honor Chi Van Dang, MD, PhD, Fellow of the...
LOS ANGELES โ The American Association for Cancer Research (AACR) will award Scarlett Lin Gomez, MPH, PhD, with the...
Report includes call to action outlining steps Congress must take to maintain momentum against cancer for all patients PHILADELPHIA...
PHILADELPHIA โ The American Association for Cancer Research (AACR) today announced its newly elected class of Fellows of the...
PHILADELPHIA โ Patients with advanced renal cell carcinoma who received the checkpoint inhibitor combination nivolumab (Opdivo) plus ipilimumab (Yervoy)...